Skip to content


Founded in 1968 by a French veterinarian, Virbac is an independent pharmaceutical company dedicated to animal health. The name Virbac is a combination of virology and bacteriology, reflecting the strong history of researching, developing and manufacturing solutions for infectious diseases in animals. Now present in more than 100 countries, Virbac offers a comprehensive and practical range of products and services covering the majority of species and pathologies. Leptospirosis vaccines and treatments for both companion and production animals are produced and marketed in many of Virbac’s subsidiaries.
Virbac innovation, based on both technological advances and listening to the customers, relies on reactive production facilities which meet the highest international quality standards. For nearly fifty years, these specific features have allowed the company to build a personalised relationship with veterinarians and farmers in every country. Through this privileged partnership, in which social, health and environmental issues come together, Virbac continues, day after day, to shape the future of animal health.

The Agricultural and Marketing Research and Development Trust, better known as AGMARDT, invests millions each year aimed at exploring market opportunities, encouraging innovative ideas and developing future leaders within the agribusiness sectors.

AGMARDT is an independent charitable Trust set up by the Government in 1987 with initial funding of $32m from the wind up of the British, Christmas Island and New Zealand Phosphate Commissions. Now with a fund of approximately $90m we invest around $3-4m annually back into the Agribusiness sector. Over $70m has already been reinvested since inception.


Please visit the AGMARDT website for more information.